24-month intervention with a specific multinutrient in people with prodromal Alzheimer's disease (LipiDiDiet): a randomised, double-blind, controlled trial

BACKGROUND: Nutrition is an important modifiable risk factor in Alzheimer's disease. Previous trials of the multinutrient Fortasyn Connect showed benefits in mild Alzheimer's disease dementia. LipiDiDiet investigated the effects of Fortasyn Connect on cognition and related measures in prod...

Descripción completa

Detalles Bibliográficos
Autores principales: Soininen, Hilkka, Solomon, Alina, Visser, Pieter Jelle, Hendrix, Suzanne B, Blennow, Kaj, Kivipelto, Miia, Hartmann, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697936/
https://www.ncbi.nlm.nih.gov/pubmed/29097166
http://dx.doi.org/10.1016/S1474-4422(17)30332-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697936/
https://www.ncbi.nlm.nih.gov/pubmed/29097166
http://dx.doi.org/10.1016/S1474-4422(17)30332-0

Ejemplares similares